Advertisment
|
|
news roundup
Elligo Health Research is partnering with Saama Technologies to develop a technology platform to transform the clinical research process and improve data management.
| advertisment
Bridging Clinical Research & Clinical Health Care – Let’s Build a Bridge
The Bridging Clinical Research & Clinical Health Care Collaborative, April 4-5, is the only forum that brings together representatives from clinical research, health care, regulatory agencies, patient advocacy groups and academia to envision a true collaborative solution to build a bridge between clinical research and health care.
 REGISTER TODAY > |
Catalent Pharma Solutions announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility.
| advertisment
Considerations for Efficient Site Contracts and Payments
Clinical trial agreement development has a tremendous impact on study start-up – integrating site-level budgets, payment terms, and Clinical Trial Management Systems set-up. By understanding the most important considerations for contract development and budget planning, you can execute a fully-integrated process that results in high-efficiency enabled contracts and payments.
 Download the White Paper |
Almac Group announced the completion of a $20 million investment in its cold chain management capabilities with the opening of a 95,000sq ft custom built cold store facility at its global headquarters in Northern Ireland.
| advertisment
Speed, Efficiency and Accuracy in Site Contracts and Payments
Negotiating investigator site contracts and budgets, coupled with delivering global investigator payments, can be challenging. By coordinating services to work together cohesively, the clinical trial process can be streamlined. Download this Executive Summary for an expert discussion on expediting the delivery of global clinical trial contract negotiation.
 Download Now |
Outlining the growing attention and pursuits around social media in adverse event reporting and advancing patient-centric initiatives in clinical trials.
| advertisment
Scientific Advice with Regulators – An Essential Tool in Early Drug Development
Live Webcast- Europe: Thursday, March 29, 2018 at 3:00pm CEST, North America: Tuesday, April 17 at 11:00am EDT
 Register now |
|
|
|
advertisment
|
|
| advertisment
Patient-Centric Complex Trial Design & Site-Less Visits: How Study Design & IRT Can Ease Patient Burdens
Live Webcast: Wednesday, March 28 at 11:00am EDT
 Register now |
| advertisment
Managing the Placebo Problem in Chronic Pain Studies
Live Webcast: Tuesday, March 27 at 11:00am EDT
 Register now |
| advertisment
PV Research Reveals Momentum Towards Cloud and AL
Live Webcast: Thursday, March 22 at 8:00am PDT
 Register now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Advertisment
|
|
Articles
The FDA's new draft IVD Guidelines will need to be factored into how pharma clinical trial sponsors use IVDs in a clinical trial, study design, timeline for protocol development, IND submission, and study initiation.
| advertisment
The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
 Register now |
Numerous factors can adversely impact study startup and its efficiency, in an industry plagued by rising development costs and increasing complexities.
|
|
advertisment
|
|
|
Blog Posts
The rare disease community in Europe has come out fighting to defend its record—and its future—in the face of what it sees as growing threats to research.
| advertisment
Achieve Better Early Clinical Development Outcomes - Faster
Use existing global network site relationships for improved early phase quality, costs and timelines
Live Webinar: Thursday, March 15 at 11:00am EDT
 Register now |
|
|
To vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
| advertisment
Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy
On Demand
 Learn more |
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
